πŸ‡ΊπŸ‡Έ FDA
Patent

US 6361992

Thyroid stimulating hormone superagonists

expired A61KA61K38/00

Quick answer

US patent 6361992 (Thyroid stimulating hormone superagonists) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Mar 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Mar 26 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
60
CPC classes
A61K, A61K38/00